AskAt Inc. announced today that AskAt received a notice of allowance dated December 19, 2017 from Office of the Controller General of Patent, Designs & Trade Marks in connection with the Application No. 762/DELNP/2006, a substance patent for its 5-HT4 Receptor Agonist (AAT-009)